案例报告:毒素症表现为埃索诺菲尔性多叶膜溢出
Takahiro Minamii1, Hiroaki Nishioka1
1Department of General Internal Medicine, Kobe City Medical Center General Hospital, Kobe, Japan.
The American journal of tropical medicine and hygiene
|March 5, 2024
概括
毒病是一种寄生虫感染,可以引起罕见的eosinophilic膜溢出. 这一案例凸显了在患有不明原因的多叶膜溢出和高乙酸细胞计数的患者中考虑毒素病的重要性.
科学领域:
- 医学寄生虫学 医学寄生虫学
- 传染性疾病 传染性疾病
- 肺部病理学 肺部病理学
背景情况:
- 毒虫病是一种常见的动物传播疾病,由圆幼虫引起.
- 肺部的干扰是常见的,但肺部溢出是罕见的.
- 埃索诺菲尔性膜溢出往往表明寄生虫或过敏状况.
研究的目的:
- 报告一种罕见的毒素病病例,呈现为异氨酸性多流液.
- 在这种情况下,强调检测毒素病的血清学测试的诊断价值.
- 要突出毒素病作为一个差异诊断的eosinophilic膜溢出.
主要方法:
- 一个74岁的男性患有呼吸障碍和右侧肺部溢液的病例报告.
- 胸腔液的分析显示出一种富含乙氨基酸的排泄物.
- 在血清和多液中检测抗托克索卡拉抗体的血清检测.
- 用阿尔本达治疗28天.
主要成果:
- 患者呈现出症状和实验室检测结果与毒病相一致.
- 血清学测试证实了毒素病.
- 患者对阿尔本达治疗反应良好.
- 胸腔溢血和埃索诺菲利亚完全消失,没有复发.
结论:
- 应考虑毒病症在异位诊断eosinophilic膜溢出,即使没有明确的暴露史.
- 血清检测对于诊断这些患者的毒素病至关重要.
- 阿尔本达是一种有效的治疗毒素病引起的多叶膜溢出.
相关概念视频
Pleural Effusion I: Introduction
980
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
980
Pleural Effusion II: Symptoms and Management
167
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
167
Pleural Disorders: Types and Brief Description
204
The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
204
Pulmonary Tuberculosis II
236
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
236
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Pulmonary Tuberculosis III
325
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
325


